STAGE IIIA LUNG CANCER AJCC V8
Clinical trials for STAGE IIIA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI takes aim at lung cancer: personalized radiation doses could boost success
Disease control Recruiting nowThis study tests whether artificial intelligence (AI) can help doctors choose the right radiation dose for each person with lung cancer. About 70 participants will receive a precise type of radiation called SBRT, with the dose guided by an AI tool. The goal is to see if this pers…
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 29, 2026 00:35 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system attack cancer more effectively. …
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 00:35 UTC
-
New immunotherapy combo shows promise in shrinking lung tumors before surgery
Disease control Recruiting nowThis study is testing whether giving a combination of two immunotherapy drugs (cemiplimab and fianlimab) before surgery can kill more cancer cells in people with early-stage non-small cell lung cancer. About 60 adults with stage IB to IIIB lung cancer will receive the drug combo …
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 00:35 UTC